Definium Therapeutics(DFTX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

DFTX Definium Therapeutics

Market Closed 11-06 16:00:00 EST

33.27

+2.91

+9.58%

盘后33.42

+0.15+0.45%

19:43 EST

High33.42	Low30.91	Vol1.28M
Open31.23	D1 Closing30.36	Amplitude8.25%
Mkt Cap4.47B	Tradable Cap4.32B	Total Shares134.37M
T/O41.75M	T/O Rate0.98%	Tradable Shares129.97M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"DFTX","market":"US","secType":"STK","nameCN":"Definium Therapeutics","latestPrice":33.27,"timestamp":1793998800000,"preClose":30.36,"halted":0,"volume":1278414,"hourTrading":{"tag":"盘后","latestPrice":33.42,"preClose":33.27,"latestTime":"19:43 EST","volume":13730,"amount":456904.3522,"timestamp":1794012180931,"change":0.15,"changeRate":0.004509,"amplitude":0.015909},"delay":0,"changeRate":0.09584980237154163,"floatShares":129971489,"shares":134366950,"eps":-3.482311,"marketStatus":"Market Closed","change":2.91,"latestTime":"11-06 16:00:00 EST","open":31.23,"high":33.415,"low":30.91,"amount":41752745.5572,"amplitude":0.08251,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-3.482311,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1794214800000},"marketStatusCode":7,"adr":0,"exchange":"NASDAQ","adjPreClose":30.36,"preHourTrading":{"tag":"盘前","latestPrice":31.24,"preClose":30.36,"latestTime":"09:29 EST","volume":3129,"amount":96119.588292,"timestamp":1793975399507,"change":0.88,"changeRate":0.028986,"amplitude":0.030962},"postHourTrading":{"tag":"盘后","latestPrice":33.42,"preClose":33.27,"latestTime":"19:43 EST","volume":13730,"amount":456904.3522,"timestamp":1794012180931,"change":0.15,"changeRate":0.004509,"amplitude":0.015909},"volumeRatio":0.6538460830779561,"impliedVol":0.9386,"impliedVolPercentile":0.5588},"requestUrl":"/m/hq/s/DFTX/tweets","defaultTab":"tweets","newsList":[{"id":"1159898319","title":"Earning Preview: Definium Therapeutics this quarter’s revenue is expected to increase by 0%, and institutional views are bullish","url":"https://stock-news.laohu8.com/highlight/detail?id=1159898319","media":"Earnings Agent","labels":["earningPreview"],"top":1,"itemType":null,"share":"https://ttm.financial/m/news/1159898319?lang=en_us&edition=fundamental","pubTime":"2026-11-02 11:16","pubTimestamp":1793589411,"startTime":"0","endTime":"0","summary":"Abstract Definium Therapeutics will release quarterly results on November 9, 2026 Post-Mkt; the market expects no product revenue, a narrower loss than last quarter, and updates on DT120 program...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Earning Preview: Definium Therapeutics this quarter’s revenue is expected to increase by 0%, and institutional views are bullish","news_tag":"earningPreview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DFTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2681812475","title":"Why Definium Therapeutics Stock Is Up 9.6% And What's Next","url":"https://stock-news.laohu8.com/highlight/detail?id=2681812475","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2681812475?lang=en_us&edition=fundamental","pubTime":"2026-11-07 19:29","pubTimestamp":1794050997,"startTime":"0","endTime":"0","summary":"BBailey PembertonNovember 7, 2026","market":"us","thumbnail":"https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=240/https://images.simplywall.st/asset/industry/6121000-choice2-card/1788952923351","type":0,"news_type":0,"thumbnails":["https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=240/https://images.simplywall.st/asset/industry/6121000-choice2-card/1788952923351"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-dftx/definium-therapeutics/news/why-definium-therapeutics-stock-is-up-96-and-whats-next","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-dftx/definium-therapeutics/news/why-definium-therapeutics-stock-is-up-96-and-whats-next","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["DFTX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680705964","title":"Definium Therapeutics presents Phase 3 data for DT120 ODT at NEI Fall Congress","url":"https://stock-news.laohu8.com/highlight/detail?id=2680705964","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2680705964?lang=en_us&edition=fundamental","pubTime":"2026-11-04 20:40","pubTimestamp":1793796059,"startTime":"0","endTime":"0","summary":"Definium Therapeutics (DFTX) announced four poster presentations at the 2026 NEI Fall Congress taking place November 5 through 8 in Colorado Spring...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/definium-therapeutics-presents-phase-3-data-for-dt120-odt-at-nei-fall-congress-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/definium-therapeutics-presents-phase-3-data-for-dt120-odt-at-nei-fall-congress-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ODT","BK4007","DFTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680053722","title":"Definium Therapeutics Reports Positive Phase 3 Results for DT120 in Generalized Anxiety Disorder","url":"https://stock-news.laohu8.com/highlight/detail?id=2680053722","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2680053722?lang=en_us&edition=fundamental","pubTime":"2026-11-04 20:00","pubTimestamp":1793793640,"startTime":"0","endTime":"0","summary":"Definium Therapeutics Reports Positive Phase 3 Results for DT120 in Generalized Anxiety DisorderDefinium Therapeutics will present positive Phase 3 results for DT120 at the NEI Fall Congress, November","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261104:nNDL1p4VT3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","DFTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680725570","title":"Definium Therapeutics to Participate in Four Healthcare Investor Conferences","url":"https://stock-news.laohu8.com/highlight/detail?id=2680725570","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2680725570?lang=en_us&edition=fundamental","pubTime":"2026-11-03 20:05","pubTimestamp":1793707539,"startTime":"0","endTime":"0","summary":"Definium Therapeutics to Participate in Four Healthcare Investor ConferencesDefinium Therapeutics management to attend Stifel Healthcare Conference in New York on Nov. 10, 2026, at 9:20 a.m. ET for fi","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261103:nNDL5tw46q:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SF","LU0053671581.USD","BK4127","EVR","PIPR","BK4007","DFTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680605247","title":"Psychedelic Drug Developers Fall After Usona Submits Depressive Drug Application","url":"https://stock-news.laohu8.com/highlight/detail?id=2680605247","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2680605247?lang=en_us&edition=fundamental","pubTime":"2026-11-03 04:01","pubTimestamp":1793649681,"startTime":"0","endTime":"0","summary":"BUZZ-Psychedelic drug developers fall after Usona submits depressive drug application** Shares of Compass PathwaysCMPS.Ofall29% to $8.22 in afternoon trading** Psychedelic stocks slide after nonprofit","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261102:nL3N46J1N6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","PSIL","BK4007","DFTX","CMPS","BK4539","GHRS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679226234","title":"Press Release: Definium Therapeutics to Report Third Quarter 2026 Financial Results on November 9, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2679226234","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2679226234?lang=en_us&edition=fundamental","pubTime":"2026-10-30 05:12","pubTimestamp":1793308320,"startTime":"0","endTime":"0","summary":"NEW YORK--(BUSINESS WIRE)--October 29, 2026--Definium Therapeutics, Inc. (NASDAQ: DFTX), a late-stage clinical biopharmaceutical company developing a new generation of therapeutics intended to address","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","DFTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679233089","title":"Definium Therapeutics Schedules Third-Quarter Results Webcast","url":"https://stock-news.laohu8.com/highlight/detail?id=2679233089","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2679233089?lang=en_us&edition=fundamental","pubTime":"2026-10-30 04:01","pubTimestamp":1793304083,"startTime":"0","endTime":"0","summary":"Definium Therapeutics Schedules Third-Quarter Results WebcastDefinium Therapeutics will report third-quarter 2026 financial results on Nov. 9, 2026, during a webcast at 4:30 p.m. EST.The results cover","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261029:nNDL2ctrsc:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DFTX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678116573","title":"Definium Therapeutics Grants Options for 93,320 Shares to Six New Employees","url":"https://stock-news.laohu8.com/highlight/detail?id=2678116573","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2678116573?lang=en_us&edition=fundamental","pubTime":"2026-10-27 04:01","pubTimestamp":1793044897,"startTime":"0","endTime":"0","summary":"Definium Therapeutics Grants Options for 93,320 Shares to Six New EmployeesDefinium Therapeutics granted six newly hired non-executive employees options to purchase 93,320 common shares under its 2026","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261026:nNDLbRL1RB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","DFTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2676687552","title":"Definium Therapeutics Investors Remain Concerned Over Psychedelics' Commercial Scalability, RBC Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2676687552","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2676687552?lang=en_us&edition=fundamental","pubTime":"2026-10-19 23:52","pubTimestamp":1792425133,"startTime":"0","endTime":"0","summary":"Definium Therapeutics  investors remain concerned over commercial scalability, evidenced by the pullback in shares, despite its DT120's strong efficacy data in generalized anxiety disorder and major depressive disorder, RBC Capital Markets said in a Monday note.The concerns relate to psychedelics' \"novel delivery paradigm\" but RBC said its survey and prior checks indicated that current infrastructure can accommodate DT120's launch and even its post-launch scale. Feedback indicated potential adoption of the product candidate, according to the brokerage.RBC also cited DT120 phase 3 data in the two indications, noting the product candidate's efficacy, safety and extended durability. The de-risked data package positions for possible approval in both generalized anxiety disorder and major depressive disorder, giving the company more access to more than $2 billion in future sales opportunities, the investment firm added.RBC has an outperform rating and $66 price target on Definium.Price: 33.","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","DFTX","BK4211","ISBC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675362809","title":"Definium Therapeutics Issues Inducement Stock Options for 45,940 Shares to New Hires","url":"https://stock-news.laohu8.com/highlight/detail?id=2675362809","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2675362809?lang=en_us&edition=fundamental","pubTime":"2026-10-14 04:01","pubTimestamp":1791921688,"startTime":"0","endTime":"0","summary":"Definium Therapeutics issues inducement stock options for 45,940 shares to new hiresDefinium Therapeutics issued inducement stock options covering 45,940 common shares to two newly hired non-executive","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261013:nNDL6mgwhb:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","DFTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674945869","title":"Definium Therapeutics Initiated at Overweight by JP Morgan","url":"https://stock-news.laohu8.com/highlight/detail?id=2674945869","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674945869?lang=en_us&edition=fundamental","pubTime":"2026-10-10 03:21","pubTimestamp":1791573660,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/DFTX/analyst-ratings","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DFTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674859274","title":"U.S. Stocks on the MOVE-SpaceX, Humana, Delta Air Lines","url":"https://stock-news.laohu8.com/highlight/detail?id=2674859274","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674859274?lang=en_us&edition=fundamental","pubTime":"2026-10-09 19:57","pubTimestamp":1791547027,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-SpaceX, Humana,Delta Air LinesOct 9 (Reuters)-US stock index futures rose on Friday as oil prices retreated on easing Middle East supply concerns, though telecom shares re","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261009:nL6N45V0LD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VHT","IE00BWXC8680.SGD","LU0320765489.SGD","LU0303823156.USD","LU2491050154.USD","LU0859254822.USD","LU2347655156.SGD","LU2125154935.USD","LU2491049909.HKD","BK4500","LU0310800379.SGD","LU2361044865.SGD","GLDN","LU0162691827.USD","HRTS","LU2462591277.SGD","LU0861579265.USD","IE00B4JS1V06.HKD","TRUM","LU0097036916.USD","SG9999014021.USD","LU0976567544.SGD","LU2324357040.USD","XLV","LU0079474960.USD","LU2357627491.SGD","SPCG","LU0072461881.USD","LU0368265764.SGD","LU0303821028.USD","LU0820561818.USD","LU1791710400.SGD","LU2211815571.USD","LU2111349929.HKD","IE00BSNM7G36.USD","LU1223082519.USD","LU0345780950.USD","LU0198837287.USD","LU0114720955.EUR","LU1223082196.USD","LU1074936037.SGD","LU0432979614.USD","LU2498475776.HKD","IE0002141913.USD","LU0965509283.SGD","LU1280957306.USD","SG9999014898.SGD","IE00BJJMRZ35.SGD","LU0055631609.USD","LU1267930227.SGD","LU0203347892.USD","ELOL","LU0642271901.SGD","LU0053666078.USD","IE00BFSS7M15.SGD","SGXZ99366536.SGD","LU2361045086.USD","LU1674673691.USD","BK4570","BK4007","IE00BFSS8Q28.SGD","BK4522","LU0158827781.USD","IE0009355771.USD","TMUS","IE00BFTCPJ56.SGD","IE00B1XK9C88.USD","GDMN","LU1267930730.SGD","LU2210150020.SGD","IE00B3T34201.USD","LU1261432733.SGD","LU0965508806.USD","LU1323610961.USD","LU0786609619.USD","LU1852331112.SGD","LU0553294199.USD","LU2552382058.USD","SLVP","LU0795875086.SGD","LU0545039389.USD","LU0661504455.SGD","LU1732800096.USD","LU0882574055.USD","IE00BKPKM429.USD","LU1861215975.USD","LU1037948897.HKD","LU2089283258.USD","LU2236285917.USD","LU1102505929.USD","AUAU","LU2462611646.USD","LU0354030511.USD","LU0528227936.USD","SG9999018857.SGD","LU0943347566.SGD","LU1069347547.HKD","LU1057294990.SGD","LU0251142724.SGD","LU0612318385.USD","LU0348723411.USD","SUNH0main","AGMI","LU1066051498.USD","LU0345780281.USD","LU0143863784.USD","LU1883866441.USD","LU2279689827.SGD","IE00BFXG1179.USD","LU1934455863.HKD","IE0002270589.USD","LU0788108826.HKD","UNHG","SG9999014880.SGD","LU0942090050.USD","LU1102505762.USD","LU1037948541.HKD","LU1720051017.SGD","LU1066053197.SGD","LU2362541273.HKD","LU0234572021.USD","IE00BJJMRX11.SGD","SG9999014906.USD","SGXZ31699556.SGD","LU1861559042.SGD","IHF","LU0048584097.USD","LU1291159041.SGD","SG9999002232.USD","LU1303367103.USD","LU0965509101.SGD","LU0456855351.SGD","LU1084165304.USD","IE00BKVL7J92.USD","LU2098885051.SGD","NEMG","IE00BJJMRY28.SGD","LU0742534661.SGD","TMED","LU1223083913.SGD","LU1914381329.SGD","JETS","IE00BZ1G4Q59.USD","LU0266512127.USD","IYH","LU2095319765.USD","LU0708994859.HKD","LU1621767810.EUR","IE00BJT1NW94.SGD","LU2244417387.USD","GDOC","LU1066051811.HKD","LU2087625088.SGD","LU0353189763.USD","LU0310799852.SGD","LU2417539215.USD","LU0330918003.SGD","FHLC","LU1868837565.USD","MARS","LU1066051225.USD","DSPC","IE00B775SV38.USD","LU1119994496.HKD","LU1035773651.USD","LU0345770993.USD","LU0630314457.HKD","LU0724618789.USD","LU1061106388.HKD","LU2089984988.USD","LU2491050071.SGD","LU1854104046.USD","LU0208291251.USD","IXJ","LU0868494617.USD","LU0107464264.USD","UN","BK4561","LU0187121727.USD","LU1430597077.USD","LU0170899867.USD","BK4581","BK4008","LU1267930573.SGD","BK4017","SG9999018865.SGD","LU2552382132.HKD","UNHU","LU0122379950.USD","LU2242649171.HKD","BK4534","LU0128525929.USD","SG9999017495.SGD","SPCU","IE00B19Z3581.USD","LU1861558580.USD","LU0070302665.USD","LU0320765059.SGD","LU0211327993.USD","LU1778281490.HKD","RXL","BK4154","SG9999001176.SGD","IE0005OL40V9.USD","LU2954938101.SGD","LU2028103732.USD","LU1988902786.USD","LU1496350502.SGD","LU1934455194.USD","LU0795875169.SGD","IE00B2B36J28.USD","WARP","BK4533","JDOC","LU0158827948.USD","LU0251132253.USD","LU0109391861.USD","IE00BMPRXN33.USD","LU0058720904.USD","LU2133065610.SGD","LU0868494708.USD","IE00B775H168.HKD","IE00BFMHRM44.USD","SG9999013999.USD","IE00BN29S564.USD","SPCQ","SG9999014005.SGD","LU0052756011.USD","LU1983260115.SGD","YSPC","LU0143863198.USD","LU1868838027.USD","UNH","SPCX","LU1674673428.USD","BK4559","MHIP","SPCF","HUM","BK4132","LU0127658192.USD","SGXZ81514606.USD","LU1861220033.SGD","LU2357305700.SGD","LU0456854461.SGD","LU0672654240.SGD","LU0342679015.USD","LU1983299246.USD","LU0310800965.SGD","LU1621768115.EUR","LU0949170772.SGD","LU0738911758.USD","SGXZ51526630.SGD","SSPC","AU","AFK","BK4549","LU0061474705.USD","LU0498741114.HKD","LU0056508442.USD","LU0266013472.USD","DFTX","LU0211331839.USD","LU0787776722.HKD","LU0345780521.USD","LU0788109121.HKD","LU1720051108.HKD","AUMI","LU0094547139.USD","LU2461242641.AUD","LU1934455277.USD","LU2125154778.USD","LU0965509010.AUD","LU1003077747.HKD","LU0820561909.HKD","GB00BDT5M118.USD","LU2999663052.SGD","TRUH","LU2247934214.USD","LU1064131342.USD","BK4515","LU2112291526.USD","SG9999014914.USD","SPCH","IE000M9KFDE8.USD","LU0149725797.USD","IE00B19Z8W00.USD","LU0211328371.USD","LU0912757837.SGD","LU0267386448.USD","LU0143551892.USD","NWMX","LU1023059493.AUD","LU0251131958.USD","SG9999002224.SGD","BK4566","IE00B19Z8X17.USD","LU1093756325.SGD","LU0289739699.SGD","LU1316542783.SGD","LU1989771016.USD","LU2360106780.USD","UNHW","LU0823416689.USD","LU0300736062.USD","LU2290526834.HKD","LU0683600562.USD","SGDM","FXH","NEM","LU0029864427.USD","LU1814569148.SGD","LU0203345920.USD","IE00B7KXQ091.USD","LU0640476718.USD","LU0353189680.USD","SNK","LU2360032135.SGD","IE00B19Z9P08.USD","LU2362540622.SGD","LU2317271919.USD","BK4588","LU2468319806.SGD","IE00B19Z9505.USD","LU0417517546.SGD","LU1551013342.USD","LU0498741890.SGD","LU1093756168.USD","LU0266512473.USD","SPCM","LU1267930490.SGD","SG9999001176.USD","LU1153585028.USD","LU0612318971.USD","LU0820562030.AUD","LU2362541513.USD","LU0314106906.USD","LU2456880835.USD","LU2361044949.HKD","SPAX","LU2360107168.USD","IE0004445015.USD","IE00B19Z3B42.SGD","LU0496365809.HKD","BK4585","LU1670628061.USD","LU0278409577.USD","LU1621768206.USD","LU2264538146.SGD","LU1854103824.USD","LU0557290698.USD","LU0496367417.USD","WSPC","LU2271345857.HKD","LU0211326755.USD","IE00B19Z9Z06.USD","LU0075056555.USD","LU0077335932.USD","LU0316494557.USD","IE0004445239.USD","LU0048573561.USD","LU1548497426.USD","LU2250418816.HKD","ORBX","LU2384288077.EUR","FMTL","LU1551013425.SGD","SPAL","IE00B894F039.SGD","LU1791710582.SGD","LU2089284900.SGD","IE00BZ9MQY76.HKD","LU0354030438.USD","IE00B1BXHZ80.USD","LU1621767737.EUR","LU1506573853.SGD","LU0689472784.USD","LOFF","LU1718418525.SGD","BK4532","GDX","IE00B7SZLL34.SGD","LU0211326839.USD","LU0345781412.USD","LU1023059063.AUD","LU0276348264.USD","BK4089","IE00B3S45H60.SGD","LU0654597011.USD","LU0238689110.USD","SG9999014013.SGD","DAL","LU1670627923.USD","SGXZ57979304.SGD","IE00BMPRXR70.SGD","IE00B4R5TH58.HKD","LU0390134368.USD","LU0708995401.HKD","LU1732799900.SGD","LU0011850046.USD","LU0256863811.USD","LU2210149790.SGD","LU2552382215.SGD","LU0128525689.USD","LOFD","LU2023251221.USD","LU0345770308.USD","IE00BMPRXQ63.HKD","SG9999001143.SGD","LU0300736492.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674313859","title":"JPMorgan Initiates Coverage on Definium Therapeutics With Overweight Rating, $84 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2674313859","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674313859?lang=en_us&edition=fundamental","pubTime":"2026-10-09 19:33","pubTimestamp":1791545608,"startTime":"0","endTime":"0","summary":"Definium Therapeutics (DFTX) has an average rating of buy and mean price target of $65.69, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from maj","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["PGF","DFTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674858428","title":"Definium up as J.P.Morgan Starts with 'overweight' Rating on LSD-Based Therapy","url":"https://stock-news.laohu8.com/highlight/detail?id=2674858428","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674858428?lang=en_us&edition=fundamental","pubTime":"2026-10-09 18:00","pubTimestamp":1791540028,"startTime":"0","endTime":"0","summary":"BUZZ-Definium up as J.P.Morgan starts with 'overweight' rating on LSD-based therapy** Shares of Definium TherapeuticsDFTX.Orise 4.2% to $35.60 premarket** J.P.Morgan initiates coverage with an \"overwe","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261009:nL4N45V0NH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DFTX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674305188","title":"Definium Therapeutics Shares up 4% Premarket After JP Morgan Initiates Coverage with Overweight Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2674305188","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674305188?lang=en_us&edition=fundamental","pubTime":"2026-10-09 17:31","pubTimestamp":1791538281,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261009:nL4N45V0N4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["DFTX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674283757","title":"Definium Therapeutics Inc : JP Morgan Initiates Coverage with Overweight Rating; Target Price $84","url":"https://stock-news.laohu8.com/highlight/detail?id=2674283757","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674283757?lang=en_us&edition=fundamental","pubTime":"2026-10-09 17:05","pubTimestamp":1791536742,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261009:nFWN45V0PL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["DFTX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674002963","title":"Definium Therapeutics Currently Down Eight Consecutive Days, on Pace for Longest Losing Streak Since January 2024","url":"https://stock-news.laohu8.com/highlight/detail?id=2674002963","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674002963?lang=en_us&edition=fundamental","pubTime":"2026-10-09 02:50","pubTimestamp":1791485400,"startTime":"0","endTime":"0","summary":"Definium Therapeutics, Inc.  is currently at $34.56, down $0.53 or 1.51%--Would be lowest close since June 18, 2026, when it closed at $24.48--On pace for largest percent decrease since Oct. 6, 2026, when it fell 1.68%--Currently down 11 of the past 12 days--Currently down eight consecutive days; down 10.02% over this period--Longest losing streak since Jan. 19, 2024, when it fell for eight straight trading days--Worst eight day stretch since the eight days ending Sept. 9, 2026, when it fell 13.3%--Down 9.2% month-to-date--Up 158.1% year-to-date; on pace for best year since 2020, when it rose 580.8%--Down 76.96% from its all-time closing high of $150.00 on March 17, 2017--Up 176.48% from 52 weeks ago , when it closed at $12.50--Down 28.67% from its 52-week closing high of $48.45 on July 9, 2026--Up 223.6% from its 52-week closing low of $10.68 on Nov. 21, 2025--Traded as low as $32.84; lowest intraday level since June 18, 2026, when it hit $23.80--Down 6.41% at today's intraday low; la","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","DFTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673509465","title":"Analysts’ Top Healthcare Picks: ArriVent BioPharma, Inc. (AVBP), Definium Therapeutics (DFTX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2673509465","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673509465?lang=en_us&edition=fundamental","pubTime":"2026-10-07 17:50","pubTimestamp":1791366612,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on ArriVent BioPharma, Inc. (AVBP), Definium Therapeuti...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-top-healthcare-picks-arrivent-biopharma-inc-avbp-definium-therapeutics-dftx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-top-healthcare-picks-arrivent-biopharma-inc-avbp-definium-therapeutics-dftx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","BK4588","XLV","AVBP","DFTX","BK4581","BK4137","HCSG","LU0128526141.USD","LABU","LU0029874061.USD","XBI","BK4139","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671172257","title":"Definium Therapeutics Issues Inducement Stock Options for 334,810 Shares to New Hires","url":"https://stock-news.laohu8.com/highlight/detail?id=2671172257","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671172257?lang=en_us&edition=fundamental","pubTime":"2026-09-29 04:01","pubTimestamp":1790625696,"startTime":"0","endTime":"0","summary":"Definium Therapeutics issues inducement stock options for 334,810 shares to new hiresDefinium Therapeutics issued inducement option grants covering 334,810 common shares to 15 newly hired non-executiv","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260928:nNDL1nPLsh:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DFTX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.definiumtx.com;ir.definiumtx.com","stockEarnings":[{"period":"1week","weight":-0.0842},{"period":"1month","weight":-0.0519},{"period":"3month","weight":-0.2789},{"period":"6month","weight":0.5088},{"period":"1year","weight":1.9339},{"period":"ytd","weight":1.4847}],"compareEarnings":[{"period":"1week","weight":-0.027},{"period":"1month","weight":-0.0539},{"period":"3month","weight":-0.0491},{"period":"6month","weight":-0.0032},{"period":"1year","weight":0.0969},{"period":"ytd","weight":0.0783}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Mind Medicine (MindMed) Inc., a clinical stage biopharmaceutical company, develops novel products to treat brain health disorders. The company's lead product candidates include MM-120, which is in phase 2 for the treatment of generalized anxiety disorder and attention deficit hyperactivity disorder; and MM-402, a R-enantiomer of 3,4-methylenedioxymethamphetamine for the treatment of core symptoms of autism spectrum disorder. The company also develops MM-110, an a3ß4 nicotinic cholinergic receptor antagonist that has completed phase 1 for the treatment of opioid withdrawal. The company is headquartered in New York, New York.","yearOnYearQuotes":[{"month":1,"riseRate":0.6,"avgChangeRate":0.130491},{"month":2,"riseRate":0.8,"avgChangeRate":0.136845},{"month":3,"riseRate":0.4,"avgChangeRate":0.072082},{"month":4,"riseRate":0.8,"avgChangeRate":0.037703},{"month":5,"riseRate":0.5,"avgChangeRate":0.01554},{"month":6,"riseRate":0.5,"avgChangeRate":0.064762},{"month":7,"riseRate":0.666667,"avgChangeRate":0.160554},{"month":8,"riseRate":0.166667,"avgChangeRate":-0.090843},{"month":9,"riseRate":0.166667,"avgChangeRate":-0.152678},{"month":10,"riseRate":0.5,"avgChangeRate":0.000457},{"month":11,"riseRate":0.333333,"avgChangeRate":0.008088},{"month":12,"riseRate":0.4,"avgChangeRate":-0.08416}],"exchange":"NASDAQ","name":"Definium Therapeutics","nameEN":"Definium Therapeutics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.53.0","shortVersion":"4.53.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Definium Therapeutics(DFTX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Definium Therapeutics(DFTX) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Definium Therapeutics,DFTX,Definium Therapeutics股票,Definium Therapeutics股票老虎,Definium Therapeutics股票老虎国际,Definium Therapeutics行情,Definium Therapeutics股票行情,Definium Therapeutics股价,Definium Therapeutics股市,Definium Therapeutics股票价格,Definium Therapeutics股票交易,Definium Therapeutics股票购买,Definium Therapeutics股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Definium Therapeutics(DFTX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Definium Therapeutics(DFTX) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}